About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, July 17th, 2017

The QualityStocks
Daily Stock List


Carolco Pictures, Inc. (CRCO)

Stock Beast, StockMister, Fortune Stock Alerts, PennyPickAlerts, Penny Stocks Profile, 1-2-3 Stock Alerts, Penny Stock Circle, Juicy Penny Stocks, and ThePUMPTracker reported earlier on Carolco Pictures, Inc. (CRCO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Carolco Pictures, Inc. is a diversified entertainment company. It engages in the financing, production, and leasing of motion picture properties. Carolco’s emphasis is on creating disruptive software and developing original film, television, as well as immersive content. Carolco Pictures has its corporate office in Boca Raton, Florida. The Company lists on the OTC Markets Group’s OTCQB.

An entertainment technology company, it formerly went by the name Brick Top Productions, Inc.  In November of 2014, media and entertainment company Brick Top Productions acquired the rights to the name Carolco and effective December 31, 2014, changed its corporate name to Carolco Pictures, Inc.

Established in 2009, Carolco is a name synonymous with international blockbusters. These include Terminator 2: Judgment Day; Total Recall; and the first three movies of the Rambo series (First Blood, Rambo: First Blood Part II, and Rambo III) and multi-billion-dollar box office revenues.

In June of 2016, Carolco Pictures put new management in place. This team is led by experienced entertainment and technology executives. Their dedication is to accomplish significant growth by way of acquisitions and production.
Recall Studios, Inc. is the wholly-owned Virtual Reality and New Media subsidiary of Carolco Pictures. Carolco purchased Recall Studios in Q3 of 2016.

Recall Studios is at the junction of new media, entertainment, as well as software development. This subsidiary creates innovative interactive experiences. Business, media, and entertainment industry leaders founded Recall Studios to meet the increasing demand for Virtual Reality and other content. Proprietary software and non-linear narrative storytelling are at the heart of all Recall Stories™.

Also, Carolco Pictures is the parent company of High Five Entertainment. High Five specializes in the development and production of television programming. This includes music series, specials, unscripted television, live events, and award shows. High Five Entertainment is headquartered in Nashville, Tennessee. It is an Emmy Award-winning entertainment production enterprise.

Carolco Pictures, Inc. (CRCO), closed Monday's trading session at $1.01, even for the day, on 75 volume with 1 trade. The average volume for the last 60 days is 227 and the stock's 52-week low/high is $0.0106/$17.00.

Rightscorp, Inc. (RIHT)

PennyStocks24, PennyPickAlerts, Fortune Stock Alerts, Stock Commander, TheNextBigTrade, OTCBB Journal, BestDamnPennyStocks, DSR News, Penny Stock Hub, StocksImpossible, Broad Street, PHUB News, MarketWireStocks, PennyDoctor, Pennystocktweeters, Wallstreet Profiler, and Stock News Now reported previously on Rightscorp, Inc. (RIHT), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Rightscorp, Inc. is a top provider of data analytics and litigation services, as well as copyright infringement protection services to support artists and owners of copyrighted property. The Company’s patent pending digital loss prevention technology centers on the infringement of digital content. This includes music, movies, software, and games. This technology ensures that owners and creators are rightfully paid for Intellectual Property (IP). Rightscorp has its headquarters in Santa Monica, California.

The Company utilizes software that monitors the global Peer‐to‐ Peer (P2P) file sharing networks to seek out and find illegally downloaded digital media. Infringers remit payment to Rightscorp for the copyright infringement and the Company makes payment to the copyright owners.

Rightscorp works closely with its clients to develop programs of education and notice, and as necessary to pursue copyright infringers for their illegal file sharing activities via notifications sent through Internet Service Providers (ISPs). Rightscorp implements existing laws to solve copyright infringements through collecting payments from illegal file sharing activities through the sent notifications.

The Company’s devotion is to the vision that digital creative works should be protected economically so that the next generation of music, movies, video games, and software can be made and its creators can prosper. Its technology identifies copyright infringers, who are offered a reasonable settlement option in comparison to the legal liability defined in the Digital Millennium Copyrights Act (DMCA). Rightscorp has monetized major media titles by way of relationships with industry leaders.

In late June, Rightscorp announced that it was granted Israeli Patent 229661, for the Company’s "System to Identify Multiple Copyright Infringements and Collecting Royalties".

Mr. Cecil Bond Kyte, Rightscorp Chief Executive Officer, said, "Online piracy continues to be a major concern worldwide with Israel holding one of the highest rates outside Europe. Last year, it was recorded that approximately 66 percent watch movies and TV shows online with only 2 percent using legal direct-view websites. There is a need in Israel for content protection and our technology is an ideal solution for curbing piracy."

Last week, Rightscorp attended the Fourth Annual Summer Institute hosted by Center for the Protection of Intellectual Property (CPIP), which took place July 11-13, 2017 in Beaver Creek, Colorado. The CPIP Summer Institute is a yearly conference for IP scholars, policy analysts, and people who work in the innovation and creative industries. Thought leaders in IP research and policy discuss the present state of affairs and work on translating ideas into policy at this exclusive event.

Rightscorp, Inc. (RIHT), closed Monday's trading session at $0.04195, down 4.66%, on 353,182 volume with 38 trades. The average volume for the last 60 days is 239,101 and the stock's 52-week low/high is $0.0102/$0.0599.

VerifyMe, Inc. (VRME)

Wall Street Mover and SmallCapVoice reported on VerifyMe, Inc. (VRME), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

VerifyMe, Inc. is a pioneer in patented physical, cyber, and biometric technologies that prevent identity theft, counterfeiting, and fraud. Fundamentally, the Company is a high-technology solutions enterprise in the field of authenticating products and people. VerifyMe pursues innovation through the development of patented products, proprietary technologies, and the creation of strategic alliances.

The Company formerly went by the name LaserLock Technologies, Inc. It changed its name to VerifyMe, Inc. in July 2015. VerifyMe is based in New York, New York. The Company lists on the OTC Markets Group’s OTCQB.

VerifyMe’s physical technology authenticates products, documents, and also currency with a set of proprietary security inks and pigments. The Company markets a wide-ranging patent portfolio. This includes patents for protecting material goods, products, and packaging. The Company’s digital technology authenticates people through performing strong, multi-factor verification via its patented digital platform.

VerifyMe™ provides a wide spectrum of technologies to authenticate products and packaging. This is from proprietary security pigments to custom track and trace solutions.

VerifyMe™ can authenticate individuals using facial recognition, fingerprint, voice and retina scanning, swipe pattern recognition, location detection and approved IP detection. VerifyMe™ ID Services replaces passwords and PINs with intuitive, user-friendly, multi-factor authentication.

The Company’s SecureLight™ can immediately change color under compact fluorescent light and LED light sources. Furthermore, its SecureLight+™ combines the covert and overt characteristics of RainbowSecure™ and SecureLight™ into a single solution.

VerifyMe’s RainbowSecure™ is a proprietary, customizable, covert anti-counterfeiting solution. It appears invisible to the human eye. However, RainbowSecure™ can be activated employing authentication devices specifically tuned to the unique frequency of each batch of ink.

VerifyMe provides advanced fraud prevention technologies to pharmaceutical companies, high-end retailers, the gaming industry, and governments globally. VerifyMe™ ID services integrate biometrics to protect corporate and consumer integrity.

In 2016, VerifyMe and the Indigo Division of HP, Inc. (HP Indigo) a worldwide printing technology leader, announced that they signed a Memorandum of Understanding (MOU) wherein the companies incorporated VerifyMe’s pigment products with HP Indigo’s ElectroInk to be used for authentication and anti-counterfeiting. This security ElectroInk is marketed and sold around the world by VerifyMe to HP Indigo customers, along with VerifyMe’s readers and authentication tools, which can be utilized in combination with security ElectroInk.

VerifyMe, Inc. (VRME), closed Monday's trading session at $0.07, even for the day, on 92,852 volume with 11 trades. The average volume for the last 60 days is 29,648 and the stock's 52-week low/high is $0.046/$0.437.

OncBioMune Pharmaceuticals, Inc. (OBMP)

Otcstockexchange, Whisper from Wall Street, Journal Transcript, and MissionIR reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products worldwide. The Company has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. OncBioMune Pharmaceuticals incorporates scientifically proven and clinically validated treatments for cancer. The Company has its corporate headquarters in Baton Rouge, Louisiana.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™ -  its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program. In addition, OncBioMune has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs.

OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients. The Company states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.   

ProscaVax™, is scheduled to start two, separate mid-stage clinical trials this year: A Phase 2 for early-stage prostate cancer at a major northwest U.S. university cancer research hospital and a Phase 2/3 study in Mexico for late-stage prostate cancer patients.

Last month, OncBioMune México, S.A. De C.V. announced the completion of the acquisition of the sanitary registration and intellectual property (IP) rights of Norepinefrine (Norepinephrine) for the Mexican market from Teva Pharmaceuticals Mexico, S.A. de C.V., the Mexican subsidiary of Teva Pharmaceuticals, Ltd., a foremost international pharmaceutical company. OncBioMune’s intention is to immediately initiate distribution of Norepinefrine via its sales channels throughout Mexico. OncBioMune engages in drug development and commercialization internationally via OncBioMune México.

Last week, OncBioMune Pharmaceuticals announced that the protocol for the planned Phase 2 trial of ProscaVax for treatment-naïve prostate cancer patients is awaiting approval from the Institutional Review Board (IRB) at the host hospital, a distinguished northeastern U.S. cancer research network. The protocol was earlier submitted to the U.S. Food and Drug Administration (FDA) and received no comments within the 30-day comment period.

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Monday's trading session at $0.075, down 6.13%, on 601,466 volume with 66 trades. The average volume for the last 60 days is 238,498 and the stock's 52-week low/high is $0.0503/$0.42.

Bagger Dave's Burger Tavern, Inc. (BDVB)

MarketWatch and The Street reported on Bagger Dave's Burger Tavern, Inc. (BDVB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bagger Dave's Burger Tavern, Inc. is the owner and operator of a full-service restaurant and bar that has locations in Michigan, Ohio, and Indiana. Bagger Dave’s is an innovative, ultra-casual restaurant and bar concept. It commenced operations in January of 2008.

The Company has its headquarters in Traverse City, Michigan. Bagger Dave’s shares trade on the OTC Markets Group’s OTCQB. Bagger Dave’s was spun off into a stand-alone company from Diversified Restaurant Holdings, Inc. on December 25, 2016, through a one-for-one distribution of common shares.

Bagger Dave’s Burger Tavern presently operates 18 Bagger Dave’s restaurants - 15 located in Michigan, one in Indiana, and two in Ohio. The Company specializes in locally-sourced, never-frozen, prime rib recipe burgers, all-natural lean turkey burgers, hand-cut fries, locally crafted beers on draft, hand-dipped milk shakes, salads, black bean turkey chili, and more.

Bagger Dave Burgers include the Santa Fe Chipotle Turkey Burger; the Asian Turkey Burger; the Mushroom & Swiss Turkey Stack; the Fiery Bleu Buffalo Turkey Burger; the Black Bean Veggie Burger; and the Blackened Mahi-Mahi Burger and more. The Company also offers its “Create Your Own Burger” option and its burgers are chef created.

Bagger Dave Sandwiches include Bagger’s Backyard BBQ Chicken Sandwich; the Tuscan Grilled Chicken Sandwich; the Grilled Chicken Parm Sandwich; Sloppy Dave’s® Sandwich; Awesome Grilled Cheese; the Egg, Bacon and Cheddar; and the California BLT. Sides include Cajun Sea Salt Tortilla Chips; Smokin’ Hot Mac ‘N’ Cheese Side; and Turkey Black Bean Chili Side, among others. 

The Bagger Dave concept differentiates itself from other full-service casual dining establishments through the absence of walk-in freezers and microwaves. This validates the Company’s fresh food offerings.

Last month, Bagger Dave's Burger Tavern announced that its shares were uplisted from the Pink Sheets to the OTCQB® Venture Market.

Mr. Michael Ansley, the Company’s Chairman, President, and Chief Executive Officer, said, “While we continue to focus on strengthening the Bagger Dave’s business, we believe this uplisting will further enhance our trading liquidity and provide additional exposure to institutional investors.”

Bagger Dave’s Burger Tavern has the right to franchise the concept in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio and Wisconsin. The Company’s business strategy is to propel top and bottom line growth via the realization of positive same-store-sales in comparable restaurant locations, as well as the successful implementation of cost cutting initiatives at the restaurant and support level.

Bagger Dave's Burger Tavern, Inc. (BDVB), closed Monday's trading session at $0.339, up 30.33%, on 673,419 volume with 74 trades. The average volume for the last 60 days is 88,306 and the stock's 52-week low/high is $0.08/$0.75.


The QualityStocks
Company Corner


Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.32, up 9.59%, on 43,598 volume with 25 trades. The stock’s average daily volume over the past 60 days is 88,729 and its 52-week low/high is $0.0913/$0.699.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”

Lexaria Bioscience Corp. is a Technology Disruptor in Edible Cannabinoids

Lexaria Appoints New Acting CFO

Converde Energy USA, Inc. (XFUL)

The QualityStocks Daily Newsletter would like to spotlight Converde Energy USA, Inc. (XFUL). Today, Converde Energy USA, Inc. closed trading at $0.0046, up 9.52%, on 1,210,889 volume with 29 trades. The stock’s average daily volume over the past 60 days is 1,496,436, and its 52-week low/high is $0.0002/$0.10.

Converde Energy USA, Inc. (XFUL), d/b/a American Energy Partners Inc., and its group of companies are dedicated to delivering solutions wherever energy production and water meet technology. The company has positioned itself to benefit from above-favorable margins on each of its subsidiaries due to the synergy of the chain of revenues.

Hydration Company of PA (HCPA)
Hydration Company of PA focuses on sourcing, implementing and distributing reclaimed water at a profit. This subsidiary's competitive advantage mainly lies within its pure volume of reclaimed water and its access to low cost treatment with high flow rates and highly concentrated solids through the technologies of XFUL's partners. Because of the volume as well as the flexibility of the model established via patent pending methodology and conveyance methods, HCPA can effectively gain market share immediately as large corporations prefer access to one source that can supply massive amounts of reclaimed water regardless of drought conditions.

American Energy Solutions, LLC
American Energy Solutions, LLC utilizes a network of partners to provide off-the-shelf and custom-designed treatment technologies that contribute to HCPA's business model of low-cost treatment and distribution. As a provider of design, this subsidiary is capable of repeatable and synergistic services across the value chain. American Energy's long-term plan is to utilize an in-house team to grow market share as water use continues to become more critical to modern industry.

Gilbert Oil & Gas Company
Gilbert Oil & Gas Company is leveraging broad industry valuation experience to move forward on its mission to add shareholder value through drilling, operating, and partnership opportunities in the upstream oil and gas space. Equipped with the in-house capabilities necessary to source and evaluate opportunities for profitability, Gilbert is positioned to become a strong customer of XFUL's other subsidiaries, providing them with the foundation to attract other customers and enter new markets.

Integrated Business Strategy
By combining ownership of water sources via Hydration Company of PA, design and treatment solutions via American Energy Solutions, and a stream of promising opportunities via Gilbert Oil & Gas Company, XFUL is essentially creating a positive revenue feedback loop. This synergistic business model also opens opportunity for higher profit margins, additional revenue, and faster growth in new markets. Disclaimer

Converde Energy USA, Inc. Company Blog

Converde Energy USA, Inc. News:

NetworkNewsBreaks – American Energy Partners, Inc. (XFUL) Featured in Exclusive Audio Interview by NetworkNewsWire

Converde Energy USA, Inc. Appoints Josh Hickman, President of Subsidiary's O&G Operations and to Board of Directors

American Energy Partners, Inc. (XFUL) d/b/a Converde Energy USA, Inc. Engages NetworkNewsWire for Corporate Communications Solutions

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.0135, up 12.50%, on 100,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 72,558, and its 52-week low/high is $0.0061/$0.09.

Epazz, Inc. (EPAZ), is an enterprise-wide software company specializing in customized web applications for higher education institutions and the public sector. Through its proprietary BoxesOS applications, the company aims to create and maintain virtual communities that facilitate enhanced communication and provide up-to-date information and content in order to streamline the decision-making process for its clients. Epazz's BoxesOS also serves as a secure digital marketplace for various types of commerce, allowing the company to meet the increasing information technology demands of the 21st century.

In addition to its BoxesOS administrative services, Epazz offers a full end-user suite of solutions designed to maximize communication and functionality with full-featured web-based intranet software. Leveraging these offerings, the company's clients gain secure access and administrative control to customized features based on their unique needs. For businesses, the value of implementing these services can be tremendous. According to data from the McKinsey Global Institute, productivity improves by as much as 25 percent in organizations with connected employees. Studying just four commercial sectors (consumer packaged goods, retail financial services, advanced manufacturing and professional services), McKinsey estimates that the fiscal contributions of implementing effective intranet solutions could amount to as much as $1.3 trillion annually.

BoxesOS also allows companies to enhance communications with stakeholders by providing one-stop access to elegant, web-enabled information dashboards designed for specific user groups. Offering the ability to create unique dashboards for each stakeholder group addresses one of the most prominent issues facing workplace intranet projects – lack of engagement. Industry data suggest that properly engaging three core types of stakeholders, including executives, implementers and users, as well as the many sub-types within each of those groups, is key to the successful implementation of digital workplace solutions.

Outside of its business software solutions, Epazz is currently addressing a rising demand in the legal cannabis industry through its ZenaPay payment system. While banks remain hesitant regarding the legality of state-approved cannabis programs, dispensaries and related businesses have been compelled to operate on a cash-only basis, creating both security concerns and inconvenience for their customers. With ZenaPay, Epazz seeks to eliminate this issue by relying on the widely-used bitcoin cryptocurrency to provide an alternative to cash transactions. These efforts are particularly intriguing when studying the forward projections associated with marijuana sales. Per ArcView Market Research, North American marijuana sales grew by an unprecedented 30 percent in 2016 to $6.7 billion, and this figure is expected to top $20.2 billion by 2021.

Epazz is led by founder, chairman and CEO Shaun Passley, Ph.D. Founding the company in February 1999, Passley has been the guiding force behind Epazz's software and product development, as well as its continuing development of future products and services. Passley is joined on the Epazz management team by Raymond Kennedy, director of sales. Kennedy has more than two decades of experience in enterprise software sales, having previously served as marketing director for HCM, Inc., where he established six new sales territories and increased overall sales by more than 30 percent. Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz, Inc. Featured on MoneyTV with Donald Baillargeon, 6/2

Epazz, Inc. Reports Increase First Quarter Revenue and Profitability; Company is Focusing on Improving Fundamentals; Increasing Sales, Reducing Operational Expenses and Increasing Income

Epazz, Inc. Launches Zenapay.com, the Company's New Cannabis Payment System

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.0749, up 7.00%, on 102,943 volume with 11 trades. The stock’s average daily volume over the past 60 days is 95,524, and its 52-week low/high is $0.07/$0.59.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Sully Project - E3 Target Drilling Underway

Kootenay Zinc Corp.: Sully Project Exploration Update

NetworkNewsWire Releases Exclusive Audio Interview with Kootenay Zinc Corp. (KTNNF)

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.09, even for the day. The stock’s average daily volume over the past 60 days is 9,628 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

Algae Dynamics Corp Announces Engagement of Atlanta-Based Broker Dealer Carter, Terry & Company

Algae Dynamics Corp Announces Memorandum Of Understanding With Bonify for Supply of Cannabis, Oil Extraction and Sales


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(IDDR) +50.00%


(SNGX) +36.23%


Stock Beast
(ACRX) +31.25%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251